ATNF Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 16:00):

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases...

Stats
Today's Volume	19 839.00
Average Volume	106 273
Market Cap	1.55M
EPS	$0 ( 2024-03-29 )
Next earnings date	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0300
ATR14	$0.0300 (1.65%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-28	Jordan Blair	Buy	0
2024-03-07	Jimenez Omar	Buy	0
2024-03-07	Smith Ryan Lewis	Buy	0
2023-12-28	Feldmann Marc	Buy	135 377	Common Stock
2023-12-15	Feldmann Marc	Sell	25 000	Common Stock

INSIDER POWER
92.01
Last 97 transactions
Buy: 4 377 554 \| Sell: 589 695

Volume Correlation

Long: 0.01 (neutral)

Short: -0.34 (neutral)

Signal:(43.826) Neutral

180 Life Sciences Corp. Correlation

10 Most Positive Correlations
KZR	0.978
BPYPN	0.976
SLN	0.976
ARVL	0.975
MPAA	0.972
USEG	0.968
WABC	0.967
ARDS	0.967
CBAN	0.967
CAAS	0.966

10 Most Negative Correlations
NVCN	-0.982
BRIVU	-0.959
STAY	-0.959
TIOA	-0.953
PPYAU	-0.952
ENER	-0.947
DSPG	-0.945
XM	-0.943
CCRC	-0.941
MSDA	-0.941

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

180 Life Sciences Corp. Correlation - Currency/Commodity

-0.23
( neutral )

0.05
( neutral )

0.00
( neutral )

-0.01
( neutral )

0.46
( neutral )

0.42
( neutral )

180 Life Sciences Corp. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-105 675 (0.00 %)
EPS:	$-52.59

Q4	2023
Revenue:	$0
Gross Profit:	$-22 660.00 (0.00 %)
EPS:	$-2.29

Q3	2023
Revenue:	$0
Gross Profit:	$-32 693.00 (0.00 %)
EPS:	$-24.53

Q2	2023
Revenue:	$0
Gross Profit:	$-28 550.00 (0.00 %)
EPS:	$-13.37

Financial Reports:

No articles found.

180 Life Sciences Corp.

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.